Free Trial

BUDA Q3 Earnings Call Highlights

Key Points

  • Record Q3 revenue reached $5.2 million, up 64% year over year, driven by 23% same-store sales growth, broader retail distribution and the refrigerated dressings business. Net income was about $866,000, roughly flat year over year, while adjusted EBITDA rose 35% to $1.3 million.
  • Buda Juice expanded its retail footprint from about 350 to 600 stores, including its first full quarter of Buda Fresh distribution at Walmart. It plans to move refrigerated dressings production to its Dallas plant in Q1 2027, which management expects to improve efficiency and reduce co-packing costs.
  • Gross margin fell to 40.8% from 44.5% a year earlier, largely due to dressings co-packing and higher diesel costs, but improved 417 basis points sequentially. The company ended September with $19.3 million in cash, no debt and an undrawn $3 million credit facility.
  • Five stocks to consider instead of BUDA.

BUDA NYSEAMERICAN: BUDA, the company behind Buda Juice, reported record third-quarter 2026 revenue of $5.2 million, up 64% from a year earlier, as stronger sales at existing stores, expanded retail distribution and a new refrigerated dressings business contributed to growth.

Same-store sales in the company’s core beverage business increased 23% year over year, while net income was approximately $866,000, or $0.07 per share, essentially flat with the prior-year quarter. Net income rose 84% from the second quarter.

Co-founder and CEO Horatio Lonsdale-Hands said the same-store result indicated that consumers familiar with the company’s products were buying more. He identified sales velocity at existing stores, new distribution and additional product lines as Buda Juice’s three principal growth engines.

Margins improve sequentially

Gross profit rose 51% to $2.1 million, but gross margin declined to 40.8% from 44.5% a year earlier. Chief Financial Officer Clint Bowers said the year-over-year decline primarily reflected interim co-packing costs for refrigerated dressings and higher diesel fuel costs.

Gross margin improved by 417 basis points from the second quarter. Bowers said the normalization of elevated lime and other produce costs was the largest factor in the sequential improvement, while Lonsdale-Hands pointed to efficiencies from higher volume.

Operating expenses rose to $1.1 million, or 21.7% of revenue, from $0.5 million, or 17% of revenue, a year earlier. Bowers attributed the increase primarily to public-company costs and non-cash stock-based compensation, as well as higher distribution costs associated with diesel prices. He noted that Buda Juice did not record federal income tax or stock-based compensation expenses in the third quarter of 2025.

Adjusted EBITDA, a non-GAAP measure, increased 35% year over year to $1.3 million, or approximately 25% of revenue, from about $1 million, or 30.5% of revenue. It rose approximately 80% from the second quarter.

Retail expansion and dressings production

The quarter was Buda Juice’s first full quarter of Buda Fresh distribution at Walmart, following an initial expansion to 246 stores across nine states. The company’s overall retail footprint grew from approximately 350 stores at the beginning of 2026 to about 600, Lonsdale-Hands said.

He said Buda Fresh Lemonade and Strawberry Lemonade were available at select Walmart stores in nine states for $1.28 per 12-ounce bottle. Asked about the rollout, he said the company was happy with its Walmart relationship and was working with Walmart and other customers on potential increases in products and stores, but did not provide specific plans.

Buda Juice also completed its first full quarter in refrigerated dressings, a business it acquired in the second quarter. The products are currently made by an outside manufacturer, but the company expects to begin transitioning production to its Dallas plant in the first quarter of 2027. Lonsdale-Hands said most equipment was in place and that moving production in-house should improve efficiency and recover a meaningful portion of co-packing costs.

During the question-and-answer session, Bowers said an earlier estimate of approximately 320 basis points remained a reasonable measure of the gross-margin effect associated with co-packing, though it had improved slightly. He clarified that the comparison assumed no ranch business, rather than the margin benefit the company would necessarily realize by bringing production in-house.

Cash and expansion plans

Buda Juice ended September with $19.3 million in cash and equivalents, no outstanding debt and an undrawn $3 million revolving credit facility. Third-quarter cash flow from operations was approximately $710,000. The increase in cash from $1.8 million at the end of 2025 primarily reflected net proceeds from the company’s January initial public offering, Bowers said.

Lonsdale-Hands said the company’s longer-term strategy contemplates regional production facilities in the eastern and western United States, but that customer demand would drive investment decisions. He said the company was discussing opportunities with existing and prospective customers, including on the East Coast, and hoped to expand there next year.

Asked about the fourth quarter, Lonsdale-Hands declined to provide guidance, saying the company would focus on discussing past performance and its longer-term vision.

About BUDA (NYSEAMERICAN:BUDA)

Buda Juice Inc. is a juice category for the supermarket fresh produce department with its cold-crafted, UltraFresh(TM) citrus juices. Buda Juice Inc. is based in DALLAS.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in BUDA Right Now?

Before you consider BUDA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BUDA wasn't on the list.

While BUDA currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines